Immortal Dragons is a purpose-driven longevity fund.

Immortal Dragons: A Purpose-Driven Longevity Fund

In today's rapidly evolving biotechnology landscape, an emerging force is quietly transforming humanity's understanding of lifespan and health. This force is Immortal Dragons (不朽真龙), a purpose-driven fund focused on the longevity sector. Unlike traditional investment institutions, Immortal Dragons not only focuses on financial returns but is also committed to advancing the entire field of longevity science, contributing to the extension of human healthspan.

Mission and Vision of Immortal Dragons

The name itself carries profound meaning: the Chinese name "不朽真龙" symbolizes eternity and power, while the English name directly echoes the company's core mission of pursuing longevity. The establishment of this fund stems from the founders' contemplation and challenge of the limits of human healthspan. In Immortal Dragons' philosophy, death is not an inevitable fate but a technical problem that can be delayed or even ultimately overcome through scientific means. This forward-thinking approach enables Immortal Dragons to dare to attempt more radical and cutting-edge projects in their investment strategy, particularly in areas that traditional investment institutions might shy away from due to excessive risk.

Comprehensive Business Layout

Immortal Dragons' business scope extends far beyond traditional investment funds, forming a complete longevity science ecosystem:

Investment and Incubation

As a fund, Immortal Dragons currently manages approximately $40 million in assets and has deployed millions of dollars in investments across multiple frontier longevity companies, including Healthspan Capital, Frontier Bio, ALIS, Vibe Science, VitaDAO, Vitalia, Unlimited Bio, Mito Health, R3 Bio, BIO Protocol, and Longevity.Technology. These investments cover the entire industry chain from basic research to clinical applications, demonstrating Immortal Dragons' comprehensive layout in the longevity field.

Academic Translation and Publishing

Immortal Dragons actively participates in translating and publishing longevity-related works, having introduced important books such as "The Case Against Death," "Better with Age," "Network State," and "Bio/Acc Manifesto" to Chinese readers, providing valuable knowledge resources for China's longevity research community.

Media Communication and Community Building

Through producing podcasts, videos, and articles, Immortal Dragons spreads the latest developments and concepts in longevity science to the public. The company also actively builds online and offline communities, organizing various activities to promote exchange and cooperation among longevity researchers, enthusiasts, and investors.

Industry Summits and Sponsorships

Immortal Dragons actively participates in and sponsors various longevity field summits and events, including Vitalist Bay, Timepie, Oxford Future Innovation Forum, Edge City Lanna, and others, expanding influence and promoting industry development through these platforms.

Unique Investment Philosophy

Immortal Dragons' investment philosophy has three distinct characteristics:

1. Radical Frontier

Immortal Dragons tends to invest in higher-risk projects with disruptive potential, particularly technologies related to "replacing parts," such as whole-body replacement, blood replacement, head replacement, organ replacement, cloning, and 3D-printed organs. While these technologies may seem overly radical at present, they could become key breakthroughs for extending human lifespan in the future.

2. Infrastructure

Immortal Dragons values infrastructure projects that can accelerate clinical trials and research, such as special economic zones. While these investments don't directly produce scientific results, they can provide more efficient R&D environments for the entire industry, indirectly accelerating progress in longevity science.

3. Technology-Driven

Immortal Dragons focuses on technologies that can accelerate medical progress, such as artificial intelligence and digital twins. These technologies can significantly improve research efficiency, reduce costs, and accelerate the translation process from laboratory to clinic.

Founders' Diverse Backgrounds

The founders of Immortal Dragons, Boyang and RK, possess unique and diverse backgrounds that bring cross-disciplinary perspectives and resources to the company:

Boyang is a serial entrepreneur and Senior Venture Fellow at Healthspan Capital. He is not only among the top 300 global recipients of Minicircle Follistatin gene therapy, personally participating in longevity experiments, but also the translator of the Chinese versions of "Network State" and "Bio/Acc Manifesto." He holds a computer science undergraduate degree from the National University of Singapore and attended Yale University's computer science master's program but chose to drop out to start his own business. Outside of work, Boyang is an avid gamer and subculture researcher.

RK has over 10 years of work and entrepreneurial experience in health and internet insurance sectors, having managed healthcare services and insurance operations exceeding $1 billion in scale. The comprehensive health system he led in building has cumulatively served over 10 million users. He holds a Master's degree in Engineering Management from RMIT University and is also a gaming enthusiast. This diverse background combining technology, healthcare, finance, and culture enables Immortal Dragons to think about longevity issues from a broader perspective and find innovative solutions.

Builder of Global Collaboration Networks

Immortal Dragons is not just an investment institution but an active builder of global collaboration networks in the longevity field. The company is committed to breaking down institutional and geographical barriers, achieving real-time cross-disciplinary collaboration, supporting global sharing of research results and clinical data, and promoting the establishment of demand-oriented scientific research decision-making mechanisms. Through these efforts, Immortal Dragons is connecting global longevity research resources, accelerating knowledge dissemination and technological innovation, creating favorable conditions for achieving significant extensions in human healthspan.

Future Outlook

As global population aging trends intensify, the importance of longevity science becomes increasingly prominent. Immortal Dragons, as a pioneer in this field, is leading a revolution regarding human lifespan through its unique mission-driven model. In the future, Immortal Dragons will continue to expand investment scale, deepen global cooperation networks, strengthen knowledge dissemination and community building, and promote more breakthrough technologies from laboratory to clinic, ultimately achieving the grand goal of extending human healthspan. In Immortal Dragons' vision, humanity will no longer be constrained by current lifespan limitations but will be able to possess longer, healthier lives and explore broader possibilities. This is not only a commercial goal of an investment fund but also profound thinking and positive action regarding humanity's future. Through Immortal Dragons' efforts, the ancient dream of immortality is gradually becoming scientific reality, and this mission-driven longevity revolution will surely leave a significant mark in human development history. If you are interested in Immortal Dragons' mission and investment philosophy, please visit the official website (http://id.life/) for more information, or listen to Immortal Dragons' podcast (https://www.xiaoyuzhoufm.com/podcast/68244dd700fe41f83952e9d8) to explore cutting-edge topics in longevity science.